23 November 2017
NWO officially awarded the Perspectief project Efficient Deep Learning (EDL) on Thursday, 21 November 2017.
- Real-time monitoring of patients during MRI-guided surgery. Project leader: Henkjan Huisman. (photo left)
- Pathology specimen analysis. Project leader: Jeroen van der Laak. (photo right)
-
Want to know more about these subjects? Click on the buttons below for more news.
RIHSRadiology & Nuclear Medicine Urological cancersWomen's cancers
Related news items
Millions of euros for study of laser treatment for glioblastoma
2 April 2021 A research group from Radboudumc and UMC Utrecht is to investigate laser treatment of a rare brain tumor, glioblastoma. 3.9 million euros has been made available for the research by Zorginstituut Nederland and ZonMw, under the auspices of the Subsidy Scheme for Promising Care. read more
Guiding the surgeon real-time tumor visualization during surgery
26 February 2020 Incomplete excision of tumor tissue negatively affects the prognosis of the patient. RIHS researcher Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic. read more
Jurgen Fütterer appointed Professor of Image-Guided Oncological Interventions
26 February 2020 RIHS researcher Fütterer is an interventional radiologist and an expert in the field of cancer imaging techniques, image-guided interventions and robotics. He is also Professor at the Robotics and Mechatronics Group at the University of Twente. read more
SPL Medical starts clinical trial with contrast agent ferrotran
11 February 2020 SPL Medical is starting an international registration study for its contrast agent Ferrotran. The study is being conducted in ten hospitals in Germany, Switzerland and the Netherlands. RIHS researcher Jelle Barentsz discovered the value of this drug in patients with lymph node metastases. read more
New Guidelines for the detection of prostate cancer MRI instead of tissue samples
3 February 2020 The module on diagnostic prostate MRI for the NVU guidelines for prostate carcinoma took effect on 29 January 2020. The development of these guidelines is due in part to the efforts of RIHS researcher Jelle Barentsz and Ivo Schoots (Erasmus MC). read more
